» Articles » PMID: 35066156

Surgery-mediated Tumor-promoting Effects on the Immune Microenvironment

Overview
Specialty Oncology
Date 2022 Jan 23
PMID 35066156
Authors
Affiliations
Soon will be listed here.
Abstract

Surgical resection continues to be the mainstay treatment for solid cancers even though chemotherapy and immunotherapy have significantly improved patient overall survival and progression-free survival. Numerous studies have shown that surgery induces the dissemination of circulating tumor cells (CTCs) and that the resultant inflammatory response promotes occult tumor growth and the metastatic process by forming a supportive tumor microenvironment (TME). Surgery-induced platelet activation is one of the initial responses to a wound and the formation of fibrin clots can provide the scaffold for recruited inflammatory cells. Activated platelets can also shield CTCs to protect them from blood shear forces and promote CTCs evasion of immune destruction. Similarly, neutrophils are recruited to the fibrin clot and enhance cancer metastatic dissemination and progression by forming neutrophil extracellular traps (NETs). Activated macrophages are also recruited to surgical sites to facilitate the metastatic spread. More importantly, the body's response to surgical insult results in the recruitment and expansion of immunosuppressive cell populations (i.e. myeloid-derived suppressor cells and regulatory T cells) and in the suppression of natural killer (NK) cells that contribute to postoperative cancer recurrence and metastasis. In this review, we seek to provide an overview of the pro-tumorigenic mechanisms resulting from surgery's impact on these cells in the TME. Further understanding of these events will allow for the development of perioperative therapeutic strategies to prevent surgery-associated metastasis.

Citing Articles

Liver Metastasis in Cancer: Molecular Mechanisms and Management.

Xu W, Xu J, Liu J, Wang N, Zhou L, Guo J MedComm (2020). 2025; 6(3):e70119.

PMID: 40027151 PMC: 11868442. DOI: 10.1002/mco2.70119.


Tumor microenvironment-responsive nanoformulations for breast cancer.

Velapure P, Kansal D, Bobade C Discov Nano. 2024; 19(1):212.

PMID: 39708097 PMC: 11663212. DOI: 10.1186/s11671-024-04122-5.


Protecting Against Postsurgery Oral Cancer Recurrence with an Implantable Hydrogel Vaccine for In Situ Photoimmunotherapy.

Chen L, Yin Q, Zhang H, Zhang J, Yang G, Weng L Adv Sci (Weinh). 2024; 11(46):e2309053.

PMID: 39467056 PMC: 11633475. DOI: 10.1002/advs.202309053.


Radiofrequency ablation: mechanisms and clinical applications.

Wu J, Zhou Z, Huang Y, Deng X, Zheng S, He S MedComm (2020). 2024; 5(10):e746.

PMID: 39359691 PMC: 11445673. DOI: 10.1002/mco2.746.


Recent advances of injectable in situ-forming hydrogels for preventing postoperative tumor recurrence.

Wang Z, Zhai B, Sun J, Zhang X, Zou J, Shi Y Drug Deliv. 2024; 31(1):2400476.

PMID: 39252545 PMC: 11389645. DOI: 10.1080/10717544.2024.2400476.


References
1.
Egan K, Cooke N, Kenny D . Living in shear: platelets protect cancer cells from shear induced damage. Clin Exp Metastasis. 2014; 31(6):697-704. DOI: 10.1007/s10585-014-9660-7. View

2.
Angka L, Martel A, Kilgour M, Jeong A, Sadiq M, de Souza C . Natural Killer Cell IFNγ Secretion is Profoundly Suppressed Following Colorectal Cancer Surgery. Ann Surg Oncol. 2018; 25(12):3747-3754. DOI: 10.1245/s10434-018-6691-3. View

3.
Otsubo D, Yamashita K, Fujita M, Nishi M, Kimura Y, Hasegawa H . Early-phase Treatment by Low-dose 5-Fluorouracil or Primary Tumor Resection Inhibits MDSC-mediated Lung Metastasis Formation. Anticancer Res. 2015; 35(8):4425-31. View

4.
Sun Z, Du C, Xu P, Miao C . Surgical trauma-induced CCL18 promotes recruitment of regulatory T cells and colon cancer progression. J Cell Physiol. 2018; 234(4):4608-4616. PMC: 6585982. DOI: 10.1002/jcp.27245. View

5.
Yang F, Wei Y, Cai Z, Yu L, Jiang L, Zhang C . Activated cytotoxic lymphocytes promote tumor progression by increasing the ability of 3LL tumor cells to mediate MDSC chemoattraction via Fas signaling. Cell Mol Immunol. 2014; 12(1):66-76. PMC: 4654365. DOI: 10.1038/cmi.2014.21. View